 Analysis: We will conduct a quasi-experimental, stepped-wedge, cluster-controlled trial. The primary outcome of this trial will be under-two mortality. We hypothesize a 25 reduction in under-two mortality rate during the intervention periods, relative to the control period. We hypothesize a 50 improvement in follow-up rates, a 30 improvement in global symptoms score, a 20 reduction in disability score, and a 20 reduction in inpatient days in hospital. We will use both quantitative and qualitative methods to assess the scalability of the intervention in terms of logistics, human resources, costs, and utilization. 